Agilent (A) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Agilent Technologies (A) reported $1.74 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 10.1%. EPS of $1.37 for the same period compares to $1.32 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.66 billion, representing a surprise of +4.6%. The company delivered an EPS surprise of +0.74%, with the consensus EPS estimate being $1.36.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Agilent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Revenue- Life Sciences and Diagnostics Markets Segment: $670 million versus the three-analyst average estimate of $631.29 million. The reported number represents a year-over-year change of -14.3%.Net Revenue- Applied Markets: $324 million versus $308.76 million estimated by three analysts on average.Net Revenue- Agilent Crosslab Group: $744 million versus $720.15 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +81% change.Revenue by End Markets- Chemical and advanced materials: $399 million versus the two-analyst average estimate of $376.71 million. The reported number represents a year-over-year change of +12.1%.Revenue by End Markets- Environmental and Forensics: $163 million versus the two-analyst average estimate of $170.7 million. The reported number represents a year-over-year change of -3%.Revenue by End Markets- Diagnostics and Clinical: $258 million compared to the $249.8 million average estimate based on two analysts. The reported number represents a change of +6.6% year over year.Revenue by End Markets- Academia and Government: $132 million versus $137.61 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3.1% change.Revenue by End Markets- Pharmaceutical: $629 million versus $581.31 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16.5% change.Revenue by End Markets- Food: $157 million versus $150.33 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9% change.View all Key Company Metrics for Agilent here>>>Shares of Agilent have returned -1.3% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilent Technologies, Inc. (A): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks